These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Amphetamines for attention deficit hyperactivity disorder (ADHD) in adults. Castells X; Blanco-Silvente L; Cunill R Cochrane Database Syst Rev; 2018 Aug; 8(8):CD007813. PubMed ID: 30091808 [TBL] [Abstract][Full Text] [Related]
9. Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis. Cortese S; Adamo N; Del Giovane C; Mohr-Jensen C; Hayes AJ; Carucci S; Atkinson LZ; Tessari L; Banaschewski T; Coghill D; Hollis C; Simonoff E; Zuddas A; Barbui C; Purgato M; Steinhausen HC; Shokraneh F; Xia J; Cipriani A Lancet Psychiatry; 2018 Sep; 5(9):727-738. PubMed ID: 30097390 [TBL] [Abstract][Full Text] [Related]
10. The effects of stimulant dose and dosing strategy on treatment outcomes in attention-deficit/hyperactivity disorder in children and adolescents: a meta-analysis. Farhat LC; Flores JM; Behling E; Avila-Quintero VJ; Lombroso A; Cortese S; Polanczyk GV; Bloch MH Mol Psychiatry; 2022 Mar; 27(3):1562-1572. PubMed ID: 35027679 [TBL] [Abstract][Full Text] [Related]
11. Methylphenidate for children and adolescents with autism spectrum disorder. Sturman N; Deckx L; van Driel ML Cochrane Database Syst Rev; 2017 Nov; 11(11):CD011144. PubMed ID: 29159857 [TBL] [Abstract][Full Text] [Related]
12. Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of adverse events in non-randomised studies. Storebø OJ; Pedersen N; Ramstad E; Kielsholm ML; Nielsen SS; Krogh HB; Moreira-Maia CR; Magnusson FL; Holmskov M; Gerner T; Skoog M; Rosendal S; Groth C; Gillies D; Buch Rasmussen K; Gauci D; Zwi M; Kirubakaran R; Håkonsen SJ; Aagaard L; Simonsen E; Gluud C Cochrane Database Syst Rev; 2018 May; 5(5):CD012069. PubMed ID: 29744873 [TBL] [Abstract][Full Text] [Related]
13. The pharmacological and non-pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: A systematic review with network meta-analyses of randomised trials. Catalá-López F; Hutton B; Núñez-Beltrán A; Page MJ; Ridao M; Macías Saint-Gerons D; Catalá MA; Tabarés-Seisdedos R; Moher D PLoS One; 2017; 12(7):e0180355. PubMed ID: 28700715 [TBL] [Abstract][Full Text] [Related]
14. Practitioner Review: Pharmacological treatment of attention-deficit/hyperactivity disorder symptoms in children and youth with autism spectrum disorder: a systematic review and meta-analysis. Rodrigues R; Lai MC; Beswick A; Gorman DA; Anagnostou E; Szatmari P; Anderson KK; Ameis SH J Child Psychol Psychiatry; 2021 Jun; 62(6):680-700. PubMed ID: 32845025 [TBL] [Abstract][Full Text] [Related]
15. Pharmacologic treatment of attention deficit hyperactivity disorder in adults: A systematic review and network meta-analysis. Elliott J; Johnston A; Husereau D; Kelly SE; Eagles C; Charach A; Hsieh SC; Bai Z; Hossain A; Skidmore B; Tsakonas E; Chojecki D; Mamdani M; Wells GA PLoS One; 2020; 15(10):e0240584. PubMed ID: 33085721 [TBL] [Abstract][Full Text] [Related]
16. Bupropion for attention deficit hyperactivity disorder (ADHD) in adults. Verbeeck W; Bekkering GE; Van den Noortgate W; Kramers C Cochrane Database Syst Rev; 2017 Oct; 10(10):CD009504. PubMed ID: 28965364 [TBL] [Abstract][Full Text] [Related]
17. Amphetamines for Attention Deficit Hyperactivity Disorder (ADHD) in adults. Castells X; Ramos-Quiroga JA; Bosch R; Nogueira M; Casas M Cochrane Database Syst Rev; 2011 Jun; (6):CD007813. PubMed ID: 21678370 [TBL] [Abstract][Full Text] [Related]
18. Pharmacological treatment for attention deficit hyperactivity disorder (ADHD) in children with comorbid tic disorders. Osland ST; Steeves TD; Pringsheim T Cochrane Database Syst Rev; 2018 Jun; 6(6):CD007990. PubMed ID: 29944175 [TBL] [Abstract][Full Text] [Related]
19. A comparison of ritalin and adderall: efficacy and time-course in children with attention-deficit/hyperactivity disorder. Pelham WE; Aronoff HR; Midlam JK; Shapiro CJ; Gnagy EM; Chronis AM; Onyango AN; Forehand G; Nguyen A; Waxmonsky J Pediatrics; 1999 Apr; 103(4):e43. PubMed ID: 10103335 [TBL] [Abstract][Full Text] [Related]
20. Efficacy, Acceptability, and Tolerability of Lisdexamfetamine, Mixed Amphetamine Salts, Methylphenidate, and Modafinil in the Treatment of Attention-Deficit Hyperactivity Disorder in Adults: A Systematic Review and Meta-analysis. Stuhec M; Lukić P; Locatelli I Ann Pharmacother; 2019 Feb; 53(2):121-133. PubMed ID: 30117329 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]